Richard C. Malabre
SVP, Chief Accounting Officer at Akebia Therapeutics · 6 reported transactions in 1 company · latest trade Feb 2, 2026
Their trades
Sold | Feb 2, 2026 | Feb 2, 2026 close $1.38 → Oct 26, 2026 close $0.64. S&P 500 +10.1% over the same days. | ||
Sold | Feb 2, 2026 | Feb 2, 2026 close $1.38 → Oct 26, 2026 close $0.64. S&P 500 +10.1% over the same days. | ||
Sold | Jun 9, 2025 | Jun 9, 2025 close $3.83 → Oct 26, 2026 close $0.64. S&P 500 +27.6% over the same days. | ||
Sold | Jun 4, 2025 | Jun 4, 2025 close $3.64 → Oct 26, 2026 close $0.64. S&P 500 +28.4% over the same days. |
$18.6K
Feb 2, 2026 close $1.38 → Oct 26, 2026 close $0.64. S&P 500 +10.1% over the same days.
$50.2K
Feb 2, 2026 close $1.38 → Oct 26, 2026 close $0.64. S&P 500 +10.1% over the same days.
$60.1K
Jun 9, 2025 close $3.83 → Oct 26, 2026 close $0.64. S&P 500 +27.6% over the same days.
$47.1K
Jun 4, 2025 close $3.64 → Oct 26, 2026 close $0.64. S&P 500 +28.4% over the same days.